BioPortUSA has partnered with a core group of professional service companies that are all leaders in their respective fields. Our partner firms have the current knowledge and experience in the U.S. market needed to help foreign-based clients successfully enter and establish a business presence in the U.S. market. Our partner firms are as follows:
Amper, Politziner and Mattia, Certified Public Accountants and Consultants
Amper’s Life Sciences Practice professionals have the expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. In addition to the traditional tax and accounting services, Amper also assists life sciences clients with services spanning the entire development cycle of companies, including:
- Bookkeeping and accounting and tax support for emerging businesses
- Assistance with grant applications and regulations
- R&D tax credit reviews
- Business and strategic planning
- Stock option and NOL accounting issues
- Sarbanes-Oxley consulting and internal audit services
- Employee benefit plan audits
- IPOs and M&A support
- Pharmaceutical guideline consulting
Amper has spent many years and has invested a substantial amount of time cultivating strong relationships with funding sources. Many clients rely on them for referrals to qualified investors that meet their lending or venture capital needs. As a result, Amper is familiar with the areas of highest concern and helps to secure the appropriate debt or equity capital to meet a growing company’s needs.
Click here to view the website.
Ashton Tweed, Ltd., Commercialization Services and Executive Talent
Ashton Tweed, Ltd., is the Executive Talent Bank Company. It is the premier source of highly experienced life sciences executives with current U.S. industry expertise. Ashton Tweed will deploy these resources to oversee all aspects of the client engagement, starting with project management through the execution of the BioPortUSA “3-D commercialization methodology.”
Ashton Tweed’s Executive Talent Bank professionals are highly experienced, entrepreneurial senior and executive level talent (Director level through C suite) with the skills required to fill roles from discovery through commercialization. Executive Talent Bank members are the most experienced practitioners with current industry expertise and a proven track record of producing results.
Click here to view the website.
Cushman & Wakefield is one of the world’s largest commercial real estate services firms. Founded in 1917, the firm has 215 offices in 56 countries, and 12,000 professionals. Cushman & Wakefield delivers integrated solutions by actively advising, implementing and managing on behalf of landlords, tenants, lenders and investors through every stage of the real estate process. These solutions include: representing clients in the buying, selling, financing, leasing and managing of assets. The firm also provides valuation advice, strategic planning and research, portfolio analysis, and site selection and space location assistance, among many other advisory services.
Cushman and Wakefield has in recent years worked for some of the world's biggest pharmaceutical companies. Amgen, Boehringer & Ingelheim, Chiron, Johnson & Johnson, Pfizer, Roche and Sanofi-Aventis are just some of the companies who have utilized Cushman and Wakefield’s services. Cushman and Wakefield’s assistance has ranged from simpler, one-off projects in individual markets to on-going strategic relationships.
Click here to view the website.
Morgan Lewis and Bockius, LLP, Legal Services
With more than 150 lawyers, scientists and other technical specialists who focus on the life sciences industry, Morgan Lewis has one of the most comprehensive practices of any U.S. law firm. Unlike other law firms, Morgan Lewis understands the scientific, business and regulatory issues that clients face and has expanded its practice to include more than 90 professionals with life sciences degrees, nearly half of which have advanced degrees in life sciences disciplines.
Morgan Lewis’s clients include many of the largest and most successful pharmaceutical companies in the world, as well as a long list of biotechnology companies, medical device manufacturers, nutritional companies, healthcare providers, renowned research and scientific institutions, and life sciences-focused investment banks and venture capital firms. As diverse as they are, these companies share a common need for comprehensive, integrated legal services that address all of the business issues and opportunities facing the industry.
Having expressly developed capabilities to cover seamlessly the complete life sciences product lifecycle, Morgan Lewis offers an unsurpassed mix of services that are critical to this industry. The Morgan Lewis Life Sciences practice focuses on all important legal areas, from transactions and litigation to regulatory approvals and compliance and protection of intellectual property, as well as key supporting capabilities, including FDA/healthcare, patents and patent litigation, immigration and antitrust. As a full-service firm with offices in the financial and regulatory centers of central importance to the industry in the U.S., Europe and Japan, Morgan Lewis is uniquely situated to provide counseling for the full range of business activities.
Click here to view the website.
PharmaNet Development Group - Clinical Trial Management
PharmaNet Development Group, a global drug development company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet offers clinical development services for early and late stage programs, as well as bioanalytical services, consulting services, and technology solutions.
For early stage programs, PharmaNet Development Group offers a broad range of services including Phase I and IIa clinical development, bioequivalence studies, regulatory affairs, and recruitment of study volunteers and patients. Bioanalytical services include method development, validation, analyses, and process optimization.
For later stage programs, PharmaNet offers all the services normally associated with conducting Phase II-IV clinical studies, with services available individually or as part of a complete clinical program. In addition, PharmaNet offers dedicated teams conducting studies in virtually all therapeutic areas, specialty areas (such as combination products) as well as Phase IV and registry studies. PharmaNet therapeutic teams include Oncology, Cardiology/General Medicine, Dermatology, Infectious Diseases, Neurosciences, and Ophthalmology.
PharmaNet Consulting comprises senior-level leaders with established credentials, proven experience, and insight acquired through working with U.S. and international regulatory agencies. Among these professionals are former senior-level FDA officials who bring unique regulatory perspective to product development. These professionals offer a broad range of experience and clinical development expertise on topics covering the entire spectrum of drug development.
Click here to view the website.
|
